|1.||Stangel, Martin: 24 articles (12/2015 - 12/2007)|
|2.||Skripuletz, Thomas: 18 articles (12/2015 - 04/2008)|
|3.||Gudi, Viktoria: 17 articles (12/2015 - 02/2009)|
|4.||Kipp, Markus: 15 articles (10/2015 - 05/2009)|
|5.||Beyer, Cordian: 14 articles (10/2015 - 05/2009)|
|6.||Clarner, Tim: 12 articles (10/2015 - 05/2009)|
|7.||Armstrong, Regina C: 12 articles (08/2013 - 10/2002)|
|8.||Kilpatrick, Trevor J: 10 articles (06/2015 - 03/2008)|
|9.||Matsushima, Glenn K: 10 articles (03/2013 - 07/2002)|
|10.||Xu, Haiyun: 9 articles (11/2015 - 05/2009)|
|1.||Demyelinating Diseases (Demyelinating Disease)
04/01/2006 - "Immunocytochemical studies of cryotome sections to analyze developmental parameters of the oligodendroglial cell population at the time of termination of cuprizone and at different times thereafter showed that in the untreated animals, there was a marked increase in the number of NG2-BrdU-positive precursor cells together with a marked decrease in MBP expression at the peak of cuprizone-induced demyelination. "
11/01/2007 - "After chronic demyelination and removal of cuprizone from the diet, remyelination and oligodendrocyte density improved significantly in hPDGF-A tg mice compared with wild-type mice. "
01/01/2015 - "The current study evaluated the protective effects of Areca catechu nut extract (ANE) on a cuprizone-induced demyelination mouse model. "
01/01/2015 - "The Protective Effects of Areca catechu Extract on Cognition and Social Interaction Deficits in a Cuprizone-Induced Demyelination Model."
09/01/2015 - "A model of demyelination induced by cuprizone (CPZ) was used to observe the function of TH in remyelination during the remission period of MS. Through weighing and behavioral tests, we found that TH improved the physical symptoms of mice impaired by CPZ. "
07/01/2015 - "Erratum to: Cuprizone Model as a Tool for Preclinical Studies of the Efficacy of Multiple Sclerosis Diagnosis and Therapy."
05/01/2015 - "Cuprizone Model as a Tool for Preclinical Studies of the Efficacy of Multiple Sclerosis Diagnosis and Therapy."
03/01/2015 - "The cuprizone (CPZ)-induced toxic demyelinating model, characterized by the degeneration of oligodendrocytes, has been utilized to study multiple sclerosis-related lesions. "
07/30/2012 - "Mitochondrium pathology in the cuprizone challenge might serve as a useful model to study the pathomechanism of multiple sclerosis subtypes (III and IV) characterized by primary oligodendrocyte degeneration."
03/01/2011 - "In this study, we investigated its expression in an experimental multiple sclerosis animal model, the cuprizone mouse model which reveals massive myelin loss. "
07/01/2015 - "In our study, we used the cuprizone mouse model to study pathological features of MS, such as inflammation, de- and remyelination, in a highly reproducible manner. "
01/01/2013 - "iNOS(-/-) mice suffered from severe inflammation following treatment with cuprizone, while WT mice had milder inflammation, as found in the previous study. "
02/01/2014 - "Interestingly, using longitudinal BLI analysis and confirmed by histological analysis, an increased migration of SVZ NSPC-derived neuroblasts towards the olfactory bulb was observed following cuprizone treatment, indicative for a potential link between CNS inflammation and increased neurogenesis. "
06/01/2007 - "Identification of genes preferentially expressed by microglia and upregulated during cuprizone-induced inflammation."
04/01/2006 - "Upon removal of cuprizone from the diet, inflammation is resolved and reparative remyelination occurs. "
|4.||Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
01/01/2015 - "Data from animal model studies, particularly studies of experimental autoimmune encephalomyelitis (EAE) and the cuprizone model, imply an important role of the UPR activation in oligodendrocytes in the development of MS. In this review we will cover current literature on the UPR and the evidence for its role in the development of MS. "
12/01/2009 - "While experimental allergic encephalomyelitis is one of the most frequently used models to investigate MS pathology and therapeutic interventions, the cuprizone model reflects a toxic experimental model. "
10/01/2015 - "The current study examined whether overexpression of Klotho (KL) in transgenic mice can enhance remyelination following cuprizone-induced demyelination and improves the clinical outcome in experimental autoimmune encephalomyelitis (EAE). "
05/01/2006 - "Demyelination is a hallmark of MS and a prominent pathological feature of several other inflammatory diseases of the central nervous system, including experimental autoimmune encephalomyelitis, an animal model of MS. Accordingly, in this study we followed the effect of IFNgamma in the demyelination and remyelination process by using an experimental autoimmune encephalomyelitis model of demyelination/remyelination after exposure of mice to the neurotoxic agent cuprizone. "
12/01/2015 - "Residual CXCR2 expression on CNS cells in Cxcr2 (+/-) →Cxcr2 (-/-) chimeric animals slowed remyelination after both experimental autoimmune encephalomyelitis and cuprizone-induced demyelination. "
|5.||Schizophrenia (Dementia Praecox)
11/01/2015 - "The present study reported the effects of cuprizone on the brain metabolites and oxidative parameters with the aim of providing neurochemical evidence for the application of the cuprizone mouse as an animal model of schizophrenia. "
11/01/2013 - "We propose that this cuprizone short-term exposure may offer a model to study some aspects of biology relevant to schizophrenia and related conditions. "
01/27/2012 - "This study suggests that the cuprizone-exposed C57BL/6 mouse is a potential animal model to investigate the impact of treatments on white matter abnormalities in schizophrenia."
01/01/2015 - "Brain metabolite changes in subcortical regions after exposure to cuprizone for 6 weeks: potential implications for schizophrenia."
05/30/2014 - "Cuprizone (CPZ) induced demyelinating mouse has been used as an animal model to examine the assumed roles of altered oligodendrocytes in the pathophysiology and treatment of schizophrenia. "
|1.||Omega-3 Fatty Acids (Omega 3 Fatty Acids)
|2.||Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)
|4.||GTP-Binding Proteins (G-Protein)
|5.||Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)
|7.||prostaglandin F2alpha receptor
|10.||Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)
|2.||Mesenchymal Stem Cell Transplantation